Pharma

If your company needs to gather information from clinical, commercial, and/or manufacturing decision-makers at pharmaceutical companies, then look no further than ISR. Our industry-leading HealthPanelTM enables us to access enough of these decision-makers in an efficient manner, saving you time and opportunity cost.

QUESTIONS WE CAN ANSWER:

  • What is my competitive position and how can I improve it?
  • What do pharmaceutical companies want and need from my company?
  • How are pharmaceutical companies making decisions and who is making them?
  • Will our new service offering succeed, why or why not?
  • How does my pharmaceutical company/department compare to other peer organizations?

SUPPORTING MATERIALS:

Service Providers

There is no doubt that over the past decade the power and influence that service providers have over the clinical development and manufacturing of pharmaceutical products has grown exponentially. Today, service providers are being marketed to, just as much as they are marketing themselves. If your company is looking for decision-makers at CROs or CMOs, then ISR should be one of your first calls. We understand the inner workings of service providers better than any market research company, period.

QUESTIONS WE CAN ANSWER:

  • What is my competitive position (awareness, familiarity, perception, usage) and how can I improve it?
  • What do service providers want and need from my company?
  • How are CROs and CMOs making decisions and who is making them?
  • Will our new service offering succeed, why or why not?

SUPPORTING MATERIALS:

  • Helped a leading e-Clinical provider introduce a new product into the market. (Goal: Understand how the product would fit into the service provider’s offering and business development process)
  • Helped a leading consulting company understand the decision-making process (DMP) and the decision-making unit (DMU) of CROs. (Goal: Improve the effectiveness of their own sales and marketing efforts)
  • Helped a venture capital company understand the perception and customer satisfaction profile of an e-Clinical company that they were interested in investing in. (Goal: Understand what the strengths and weaknesses of the company’s brand and operation were prior to investing)

Patients

There might not be a more talked about topic in the pharmaceutical industry than “patient-centric.” Patients are such a critical component in clinical development, manufacturing/packaging, and commercial operations that their thoughts and opinions cannot be overlooked.

QUESTIONS WE CAN ANSWER:

  • What does the patient/customer journey look like?
    • Clinical trial design and decision-making
    • Treatment pathway(s)
    • Product usage
    • A day in the life, disease/condition understanding
  • What do patients value?
  • How do patients make decisions? Where do they go and who do they trust for information?
  • How do patients perceive a product and what alternatives do they consider before making a decision?

SUPPORTING MATERIALS:

  • Helped a major diagnostic/medical device company understand a complicated disease state and how their product fit into the treatment pathway. (Goal: Better educate their sales force and assist with product development)
  • Helped a top-10 CRO understand, on a worldwide basis, what motivates a particular patient population to participate in a clinical trial. (Goal: Develop messaging that would improve patient recruitment and retention)
  • Isr produced a syndicated market research report titled “Headaches: Current Treatments, Unmet Needs, and Patient Recruitment” in which we identify and explores the patterns and preferences surrounding the needs, treatments, and side-effects of patients living with chronic cluster headaches, tension headaches, and migraines.

Investigators Study Coordinators

Industry Standard Research has access to thousands of site personnel around the globe. They're critical not only to the success of your clinical trial, but to the success of the clinical trials industry. Below are some of the common reasons we regularly speak with site personnel.

QUESTIONS WE CAN ANSWER:

  • What are the primary drivers of patient recruitment challenges and successes?
  • How do sites view clinical trial technologies? What are their experiences with - and requirements for - these technologies?
  • What makes for an effective CRA? How satisfied are sites with your CRAs?
  • What drives investigators to participate in clinical research? Science? Altruism? Finances?
  • How feasible is your study's protocol? Are the inclusion/exclusion criteria realistic?

SUPPORTING MATERIALS:

Physicians

You already know you need to understand prescribers and their needs. They’re one of your most important constituents. Make sure you use a research provider who understands your needs and speaks prescribers’ language.

QUESTIONS WE CAN ANSWER:

  • What makes for a welcomed sales representative? What are prescribers' experiences with your reps?
  • What are prescribers' experiences with web-based product details? What makes for a good web experience and what pitfalls do you need to avoid when crafting yours?
  • What are the largest unmet needs in the treatment of certain conditions?

SUPPORTING MATERIALS:

Pharmacists

These are a difficult-to-reach constituent and ISR has access. Their perspective in the healthcare chain is unique in its proximity to the medicines and the people taking them. With increasing scrutiny on pricing and the availability of generics and biosimilars, they’re a critical part of the product decision-making process.

QUESTIONS WE CAN ANSWER:

  • What are the most frequently asked questions about a medicine?
  • How are biosimilars changing the landscape?
  • Under what conditions are pharmacists motivated to dispense a generic? Are those any different from a biosimilar product?
  • What kind of pressure are they under from payers?

SUPPORTING MATERIALS:

Payers

No product is launched or optimized in its market penetration without understanding its place in the landscape of competitive products including pricing, clinical outcomes and unmet needs.

QUESTIONS WE CAN ANSWER:

  • What unmet needs does the payer perceive exist in the treatment of an indication?
  • What are the necessary attributes of a product for top placement in their formulary?
  • What are their strategies for the reimbursement of biosimilars and their reference products?

SUPPORTING MATERIALS:

ISR CUSTOMERS